Monday, August 24, 2015

CardioBrief: At Last, a Positive Diabetes Drug Outcomes Trial?

(MedPage Today) -- Study of SGLT2 inhibitor empagliflozin may be the first to show cardiovascular benefit
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)